Hoa Lac Stem cell group and Biotalentum Ltd, Hungary signed a Memorandum of Understanding (MOU) on study on using stem cell based models to screen anti-tumor active substances from Vietnamese medicinal plants. Both parties agree to conduct and promote research activities to
- Establish stem-cell based models for drug screening including using the human glioblastoma cells for anticancer screening and using human induced pluripotent stem (iPSC)-derived Neuronal Stem cells (iPSC-NPC) and neurons for neurotoxicity screening.
- Apply the developed model for screening chemical compounds extracted and purified from Vietnamese medicinal natural resources with anticancer potential.
- Study the methods of transformation of IPSCs into glioblastoma (stem) cells.
- Develop scientific plans for further applications of stem cell based models in pharmaceutical industry including patent application, publication of research results, training and transfer of technology.
